These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 4009947

  • 1. [Laboratory and clinical studies on BRL 25000 (clavulanic acid -amoxicillin) granules in the pediatric field].
    Cho K, Sakata H, Fujita K, Yoshioka H, Mukai N.
    Jpn J Antibiot; 1985 Feb; 38(2):253-62. PubMed ID: 4009947
    [Abstract] [Full Text] [Related]

  • 2. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Sato Y, Iwata S, Akita H, Murai T, Ibara M, Oikawa T, Osano M.
    Jpn J Antibiot; 1985 Feb; 38(2):327-41. PubMed ID: 3847521
    [Abstract] [Full Text] [Related]

  • 3. [Bacteriological and clinical evaluation of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Haruta T, Kuroki S, Okura K, Kobayashi Y.
    Jpn J Antibiot; 1985 Feb; 38(2):359-72. PubMed ID: 3847523
    [Abstract] [Full Text] [Related]

  • 4. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field].
    Iwai N, Taneda Y, Shibata M, Mizoguchi F, Katayama M.
    Jpn J Antibiot; 1985 Feb; 38(2):342-58. PubMed ID: 3847522
    [Abstract] [Full Text] [Related]

  • 5. [Clinical study of BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
    Nagamatsu I, Horiguchi S, Hatae T.
    Jpn J Antibiot; 1985 Feb; 38(2):287-95. PubMed ID: 3847518
    [Abstract] [Full Text] [Related]

  • 6. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Toyonaga Y, Kurosu Y, Sugita M, Nakamura H, Takahashi T, Hori M.
    Jpn J Antibiot; 1985 Feb; 38(2):373-413. PubMed ID: 3847524
    [Abstract] [Full Text] [Related]

  • 7. [Laboratory and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Nishimura T, Tabuki K, Takashima T, Takagi M.
    Jpn J Antibiot; 1985 Feb; 38(2):431-40. PubMed ID: 4009952
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Miyachi Y, Ueda S, Hayakawa F, Nakashima T, Hakamada S, Kuno K.
    Jpn J Antibiot; 1985 Feb; 38(2):423-30. PubMed ID: 4009951
    [Abstract] [Full Text] [Related]

  • 10. [Experimental and clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules in the field of pediatrics].
    Motohiro T, Tanaka K, Koga T, Shimada Y, Tomita N, Nishiyama T, Ishimoto K, Tominaga K, Iriki T, Harada M.
    Jpn J Antibiot; 1985 Feb; 38(2):481-506. PubMed ID: 3892076
    [Abstract] [Full Text] [Related]

  • 11. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Sunakawa K, Ishizuka Y.
    Jpn J Antibiot; 1985 Feb; 38(2):319-26. PubMed ID: 3892075
    [Abstract] [Full Text] [Related]

  • 12. [Experimental and clinical evaluation of the BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Shinozaki T, Meguro H, Fujii R, Mashiko Z, Okamoto Y, Arimasu O.
    Jpn J Antibiot; 1985 Feb; 38(2):269-86. PubMed ID: 4009949
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules on skin and soft tissue infections in the field of pediatrics].
    Motohiro T, Tanaka K, Koga T, Shimada Y, Tomita N, Nishiyama T, Ishimoto K, Tominaga K, Iriki T, Harada M.
    Jpn J Antibiot; 1985 Feb; 38(2):507-37. PubMed ID: 3892077
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the field of otorhinolaryngology].
    Kawamura S, Sugita R, Fujimaki Y, Deguchi K.
    Jpn J Antibiot; 1983 Mar; 36(3):500-8. PubMed ID: 6553606
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of BRL 25000 (clavulanic acid-amoxicillin) on bacterial flora in human feces].
    Motohiro T, Tanaka K, Koga T, Shimada Y, Tomita N, Sakata Y, Fujimoto T, Nishiyama T, Kuda N, Ishimoto K.
    Jpn J Antibiot; 1985 Feb; 38(2):441-80. PubMed ID: 3847525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.